Circulating methylated DNA

James G. Herman

Research output: Contribution to journalArticle

Abstract

Early detection of cancer would facilitate better management of patients, because survival is greatly affected by stage of presentation. Circulating nucleic acids represent a biomarker that might be used in the early detection of cancer. In addition, such biomarkers could potentially be used to follow the progression of patients with cancer. DNA methylation of the promoter region CpG islands of genes represents one such nucleic acid-based marker, and possesses some advantages over other approaches. These include the stability of DNA as a molecule, the ability to detect such changes using simple polymerase chain reaction-based approaches, and the potential for methylated DNA to be preferentially present in nucleosomes in plasma or serum. These factors are presented and their impact on the detection of methylated DNA circulating in the bloodstream is demonstrated.

Original languageEnglish (US)
Pages (from-to)33-39
Number of pages7
JournalAnnals of the New York Academy of Sciences
Volume1022
DOIs
StatePublished - 2004

Fingerprint

Biomarkers
Early Detection of Cancer
Nucleic Acids
DNA
CpG Islands
Nucleosomes
Polymerase chain reaction
DNA Methylation
Genetic Promoter Regions
Genes
Plasmas
Polymerase Chain Reaction
Molecules
Survival
Serum
Neoplasms
Cancer
Gene
Plasma
Progression

Keywords

  • Cancer detection
  • DNA
  • Methylation

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Circulating methylated DNA. / Herman, James G.

In: Annals of the New York Academy of Sciences, Vol. 1022, 2004, p. 33-39.

Research output: Contribution to journalArticle

Herman, James G. / Circulating methylated DNA. In: Annals of the New York Academy of Sciences. 2004 ; Vol. 1022. pp. 33-39.
@article{dd33077b09ef4e18b43974f7740759eb,
title = "Circulating methylated DNA",
abstract = "Early detection of cancer would facilitate better management of patients, because survival is greatly affected by stage of presentation. Circulating nucleic acids represent a biomarker that might be used in the early detection of cancer. In addition, such biomarkers could potentially be used to follow the progression of patients with cancer. DNA methylation of the promoter region CpG islands of genes represents one such nucleic acid-based marker, and possesses some advantages over other approaches. These include the stability of DNA as a molecule, the ability to detect such changes using simple polymerase chain reaction-based approaches, and the potential for methylated DNA to be preferentially present in nucleosomes in plasma or serum. These factors are presented and their impact on the detection of methylated DNA circulating in the bloodstream is demonstrated.",
keywords = "Cancer detection, DNA, Methylation",
author = "Herman, {James G.}",
year = "2004",
doi = "10.1196/annals.1318.006",
language = "English (US)",
volume = "1022",
pages = "33--39",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Circulating methylated DNA

AU - Herman, James G.

PY - 2004

Y1 - 2004

N2 - Early detection of cancer would facilitate better management of patients, because survival is greatly affected by stage of presentation. Circulating nucleic acids represent a biomarker that might be used in the early detection of cancer. In addition, such biomarkers could potentially be used to follow the progression of patients with cancer. DNA methylation of the promoter region CpG islands of genes represents one such nucleic acid-based marker, and possesses some advantages over other approaches. These include the stability of DNA as a molecule, the ability to detect such changes using simple polymerase chain reaction-based approaches, and the potential for methylated DNA to be preferentially present in nucleosomes in plasma or serum. These factors are presented and their impact on the detection of methylated DNA circulating in the bloodstream is demonstrated.

AB - Early detection of cancer would facilitate better management of patients, because survival is greatly affected by stage of presentation. Circulating nucleic acids represent a biomarker that might be used in the early detection of cancer. In addition, such biomarkers could potentially be used to follow the progression of patients with cancer. DNA methylation of the promoter region CpG islands of genes represents one such nucleic acid-based marker, and possesses some advantages over other approaches. These include the stability of DNA as a molecule, the ability to detect such changes using simple polymerase chain reaction-based approaches, and the potential for methylated DNA to be preferentially present in nucleosomes in plasma or serum. These factors are presented and their impact on the detection of methylated DNA circulating in the bloodstream is demonstrated.

KW - Cancer detection

KW - DNA

KW - Methylation

UR - http://www.scopus.com/inward/record.url?scp=3242670448&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3242670448&partnerID=8YFLogxK

U2 - 10.1196/annals.1318.006

DO - 10.1196/annals.1318.006

M3 - Article

C2 - 15251936

AN - SCOPUS:3242670448

VL - 1022

SP - 33

EP - 39

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

ER -